Ridgeback Capital Investments L.P. - 31 Dec 2025 SCHEDULE 13G/A Report for Lenz Therapeutics, Inc. Common Stock, par value $0.00001 per share (LENZ)

Filing Manager
Ridgeback Capital Investments L.P.
Reporting Manager
Ridgeback Capital Investments L.P.
Security
Lenz Therapeutics, Inc. Common Stock, par value $0.00001 per share
Symbol
LENZ
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 16:03:03 UTC
Date of event
31 Dec 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Ridgeback Capital Investments L.P. 0% 0 0 0 /s/ Nicole Venezia Nicole Venezia, General Counsel
Ridgeback Capital Investments LLC 0% 0 0 0 /s/ Nicole Venezia Nicole Venezia, General Counsel
Ridgeback Capital Management LLC 0% 0 0 0 /s/ Nicole Venezia Nicole Venezia, General Counsel